Healthcare company-building profile
BU Ignition Award Program
Boston University (Technology Development)
Source-based profile
Program at a Glance
- Program type
- Accelerator
- Program category
- University accelerator
- Organization
- Boston University (Technology Development)
- Organization type
- University
- Location
- Boston, Massachusetts
- Company stage served
- Research or idea stage
- Cohort or participation model
- Annual award cycle with pre-proposals due December 1
- Investment or funding offered
- Yes
- Published investment terms
- Up to $75,000 in non-dilutive proof-of-concept funding per award
- Equity or fee model
- No equity
- Clinical or hospital connection
- Not publicly documented
- Application status
- Active
Public description
About the program
The Ignition Award is Boston University's proof-of-concept translational funding program, offering up to $75,000 to BU researchers to advance an idea with clear commercial potential, with pre-proposals due each December 1. It is administered by BU Technology Development, which maintains dedicated business development leads for life sciences and medical technology. BU reports more than 200 companies built on university discoveries, including DermaSensor, which received FDA clearance for skin cancer detection technology.
What the program publicly emphasizes
Focus areas and features
- Category: University accelerator
- Program structure: Annual award cycle with pre-proposals due December 1
- Published terms: Up to $75,000 in non-dilutive proof-of-concept funding per award
Publicly documented people and network
Program leadership and alumni
- Program leader
- Michael Pratt — Managing Director, BU Technology Development
- Notable alumni named in public materials
- DermaSensor
Sources
External source links open in a new tab.